Clinical Trials Logo

Acute Respiratory Disease clinical trials

View clinical trials related to Acute Respiratory Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT05546073 Completed - Acute Illness Clinical Trials

Advanced Point-of-care Technology During In-home Assessment Among Older Adults

Start date: October 14, 2022
Phase: N/A
Study type: Interventional

Due to ageing-related physiological changes, diagnosing older adults is challenging. Delayed disease recognition lead to adverse health outcomes and increased hospitalisation, which is why there is a need to develop new procedures for timely diagnosis and treatment of older adults. Point-of-care technology, e.g. focused lung ultrasound scan and bedside analysis of blood samples (leucocytes with differential count, electrolytes and creatinine) carried out in the patients' home may support clinical decision-making, and potentially reduce acute hospital admissions. The trial's overall aim is to investigate whether increased point-of-care technology, i.e. focused lung ultrasound scan and bedside blood analysis, used as in-home diagnostics in older adults with acute respiratory symptoms, can qualify the general practitioner's clinical decision-making for early treatment initiation and eventually reduce acute hospital admission.

NCT ID: NCT05095090 Active, not recruiting - Asthma Clinical Trials

Study of Hospitalised Patients With Acute Respiratory Conditions

CHESTY
Start date: February 2, 2022
Phase:
Study type: Observational

This observational study aim to characterise patients admitted to hospital with an acute respiratory condition, or acute worsening of their chronic lung condition. This will enable identification of predictors of future risk, as well as develop potential interventions targets.

NCT ID: NCT05054114 Completed - Clinical trials for COVID-19 Respiratory Infection

Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19

Start date: December 21, 2020
Phase: N/A
Study type: Interventional

It is known that the pretreatment with exogenous interferon blocks SARS-CoV-2 infection, but intervention is much more effective if administered prior to infection. In this study the primary aim is to investigate 28-day regime of nasal interferon gama use in healthy participants for COVID-19 and other respiratory infections prevention.

NCT ID: NCT02079701 Completed - Pneumonia Clinical Trials

Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits

Start date: October 2000
Phase: Phase 4
Study type: Interventional

The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: - determining the etiology of clinical pneumonia among U.S. military trainees; - comparing the serotype distribution of S. pneumoniae (Sp) isolates recovered from vaccinated and nonvaccinated trainees diagnosed with pneumonia; and - comparing days lost from training due to pneumonia or acute respiratory disease for vaccinated and nonvaccinated subjects.

NCT ID: NCT01288846 Not yet recruiting - Febrile Illness Clinical Trials

Medication List in and Out of Hospital

Start date: March 2011
Phase: N/A
Study type: Observational

30 patients acute hospitalized to medical ward and their medication records are examined. It is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient. The record of the changes made during hospital stay is examined, whether they are justified in the discharge summaries and whether they are described in the medical list. After a month is to find out if the GP has recorded or possibly rejected changes to medication made in hospital.